Filing Details

Accession Number:
0001371285-22-000015
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2022-02-01 17:30:23
Reporting Period:
2021-11-25
Accepted Time:
2022-02-01 17:30:23
Original Submission Date:
2021-12-30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1371285 Trupanion Inc. TRUP Hospital & Medical Service Plans (6324) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1657025 Margaret Tooth C/O Trupanion, Inc.
6100 4Th Avenue South, Suite 200
Seattle WA 98108
Co-President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-25 1,219 $0.00 18,913 No 4 M Direct
Common Stock Disposition 2021-11-25 480 $125.23 18,433 No 4 S Direct
Common Stock Disposition 2021-12-28 350 $137.00 18,083 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit (RSU) Disposition 2021-11-25 1,219 $0.00 1,219 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,220 2022-02-25 No 4 M Direct
Footnotes
  1. Restricted stock units convert into common stock on a one-for-one basis.
  2. This Form 4 amends the incorrect disclosure that shares were withheld by issuer to satisfy taxes and corrects the disclosure to report that shares were sold by issuer to satisfy tax obligations.
  3. This Form 4 discloses the shares of common stock that have been sold by the issuer to satisfy its income tax withholding and remittance obligations in connection with the vesting of the restricted stock units.
  4. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.22 to $126.70 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (4).
  5. The exercise and sale reported were effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person on May 28, 2021, in order to implement a plan of financial diversification. Accordingly, the reporting person had no discretion with regard to the timing of the transaction.
  6. The RSU vests and will convert to common stock of the Issuer as to 1/4th of the total shares on February 25, 2019, after which 1/16th of the total shares vest quarterly, subject to continued service through each vesting date.